I don't know whether anyone else saw this story that came out of the ADA scientific sessions, but Novo have just completed a phase 2 trial of Icodec with people with Type 2 Diabetes. Icodec is a once weekly long acting insulin. The phase two trial data for those with type 2 found that the insulin performed no worse than Lantus. There's also a trial ongoing with people with type 1. There are some more details here, but I wondered what people think about a long acting insulin that only needs injecting once per week?